# Radar Ventures

> Radar Ventures is a VC fund backing Biotechnology and Robotics. See 21 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 21
- Last investment: Jun 2026
- Lead investor: 5%
- Last updated: Aug 2026

Radar Ventures is a VC fund focused on Biotechnology and Robotics. Radar Ventures operates as an venture capital firm.

## Contacts

5 contacts available for Radar Ventures. Shizune tracks 1 team members at Radar Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/radar-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.8M–$11M |
| Series A | $3.2M–$15M |
| Venture - Series Unknown | $19M–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 19% |
| Robotics | 3 | 14% |
| Health Care | 3 | 14% |
| Food and Beverage | 3 | 14% |
| Artificial Intelligence | 3 | 14% |

35 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 12 | 57% |
| Series A | 3 | 14% |
| Venture - Series Unknown | 2 | 10% |
| Pre-Seed | 1 | 5% |
| Initial Coin Offering | 1 | 5% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Australia | 7 | 33% |
| United States | 4 | 19% |
| New Zealand | 2 | 10% |
| Hong Kong | 1 | 5% |
| Singapore | 1 | 5% |

6 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Rodney Drury | General Partner | 4 | https://shizune.co/investors/profile/rod-drury |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Acumino | Acumino offers next-generation, AI powered robot models for the execution of highly dexterous tasks in industrial automation settings. The Acumino AI is trained on the most accurate data of robot interactions and facilitates the deployment of next-generation intelligent robot workers in a fast, scalable, reliable, cost-efficient manner, unlockingunmatched dexterity & ROI. | $11.7M | Seed | Jun 24, 2026 |  |
| OncoRes Medical | OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure. | $19.2M | Venture - Series Unknown | Feb 12, 2026 |  |
| Diag-Nose.io | Diag-Nose Medical is a novel diagnostic tool that develops non-Invasive diagnostics for better rhinology treatments. The company is working on an affordable, rapid, and non-invasive self-test to determine the right treatment pathway for patients with acute sinusitis and to promote antibiotic stewardship for clinicians.Diag-Nose Medical flagshipproduct, the “RHINOSENSE” is a point-of-care test that combines non-invasive nasal sampling, lateral flow immunoassays, and host-immune markers to differentiate between viral, bacterial, and allergy mediated sinusitis. | $2M | Seed | Jan 30, 2025 |  |
| Marama Labs | Marama Labs is a developer of a novel UV-Vis spectroscopy technology for scientific-analytical instrumentation. It assists customers in identifying and measuring turbid samples' characteristics by using light's spectral properties. It offers an ultra-violet and visible spectrophotometer for measuring absorption, extinction, and scatteringspectra of clear and turbid liquids to help customers keep their samples intact, reduce sample preparation steps, and improve measurement turnaround time. | $2.1M | Seed | Dec 19, 2024 |  |
| Xylo Bio | Xylo Bio is a drug development company that focuses on next-generation psychedelics. With psychedelic molecules as the starting point, our goal is to develop medicines that are widely available as improved treatments to currently available SSRI medications. | $8M | Seed | Jun 02, 2024 |  |
| Marama Labs | Marama Labs is a developer of a novel UV-Vis spectroscopy technology for scientific-analytical instrumentation. It assists customers in identifying and measuring turbid samples' characteristics by using light's spectral properties. It offers an ultra-violet and visible spectrophotometer for measuring absorption, extinction, and scatteringspectra of clear and turbid liquids to help customers keep their samples intact, reduce sample preparation steps, and improve measurement turnaround time. | $1.9M | Seed | Jan 22, 2024 |  |
| Eden Brew | Eden Brew is a food and beverage company providing a range of animal-free and precision-fermented milk and dairy products. | $15.4M | Series A | Oct 03, 2023 |  |
| Cortical Labs | Cortical Labs is a biological computing startup that is revolutionizing computing by integrating living neurons into chips. The biOS from Cortical Labs creates their reality and transmits data about it via electrical signals. The activity of the neuron is then translated into actions within that reality. The mind perceives these actions as having apositive or negative impact on biOS, which it then adapts to in order to enhance that feedback. The self-programming, infinitely flexible human neuron is the product of four billion years of evolution. | $10M | Seed | Apr 19, 2023 |  |
| Cortical Labs | Cortical Labs is a biological computing startup that is revolutionizing computing by integrating living neurons into chips. The biOS from Cortical Labs creates their reality and transmits data about it via electrical signals. The activity of the neuron is then translated into actions within that reality. The mind perceives these actions as having apositive or negative impact on biOS, which it then adapts to in order to enhance that feedback. The self-programming, infinitely flexible human neuron is the product of four billion years of evolution. | $10M | Seed | Apr 19, 2023 |  |
| Turnto | We’re on a mission to speed up health breakthroughs for everyone.Health breakthrough information lives all over the place and solutions are not being captured from the crowd quickly enough. We are building a home for all voices and insights - for every single health condition.Our mobile app generates daily health breakthroughs with generativeAI and the crowd. We are live on the app store being used by patients/carers with Cerebral Palsy, Long Covid, ME/CFS, and Parkinson's. With MS and Spinal Cord Injury up next.Built by patients and carers to solve a problem we live with every day. Backed by world-class operators and investors, including the founders of Canva, Google Maps, Xero, and Afterwork. |  | Pre-Seed | Jan 01, 2023 |  |

10 of 21 investments shown.

## Co-investors
- [The Yield Lab Europe](https://shizune.co/investors/profile/the-yield-lab-europe) — VC Fund, 4 deals together
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund, 3 deals together
- [Horizons Ventures](https://shizune.co/investors/profile/horizons-ventures) — VC Fund, 3 deals together
- [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund, 2 deals together
- [Brandon Capital](https://shizune.co/investors/profile/brandon-capital-partners) — VC Fund, 2 deals together
- [Breakthrough Victoria](https://shizune.co/investors/profile/breakthrough-victoria) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Artesian VC](https://shizune.co/investors/profile/artesian-capital-management) — VC Fund
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund

## Featured in investor lists
- [Consumer VC Funds in Oceania](https://shizune.co/investors/consumer-vc-funds-oceania)
- [Biotech VC Funds in Oceania](https://shizune.co/investors/biotech-vc-funds-oceania)
- [Biotechnology Investors in Australia](https://shizune.co/investors/biotechnology-investors-australia)
- [Biotechnology VC Funds in Australia](https://shizune.co/investors/biotechnology-vc-funds-australia)
- [Biotech Investors in Australia](https://shizune.co/investors/biotech-investors-australia)
- [Biotech VC Funds in Australia](https://shizune.co/investors/biotech-vc-funds-australia)

## FAQ

### What does Radar Ventures invest in?

Radar Ventures invests primarily in Biotechnology, Robotics and Health Care startups, most often at Seed and Series A stage. Most of the 21 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Radar Ventures's check size?

Radar Ventures typically joins rounds of $1.8M–$11M at Seed, $3.2M–$15M at Series A and $19M–$30M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Radar Ventures participates in.

### How do I contact Radar Ventures?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Radar Ventures?

The team at Radar Ventures includes Rodney Drury (General Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co